Copper flurbiprofen complex, identified by the CAS number 133214-12-7, is a coordination compound formed between copper ions and flurbiprofen, a non-steroidal anti-inflammatory drug (NSAID). This complex exhibits unique characteristics due to the interaction between the metal ion and the organic ligand. Typically, such complexes can enhance the solubility and bioavailability of the drug, potentially leading to improved therapeutic effects. The presence of copper may also impart additional biological activities, such as antioxidant properties. The complex is generally characterized by its stability, which can be influenced by factors such as pH and the presence of other ions in solution. In terms of pharmacological applications, copper flurbiprofen complex may be explored for its efficacy in pain management and inflammation reduction, similar to flurbiprofen itself, but with the added benefits that metal coordination can provide. Further studies are often necessary to fully understand its pharmacokinetics, mechanisms of action, and potential side effects compared to the free drug.

copper flurbiprofen complex

133214-12-7: Copper flurbiprofen complex, identified by the CAS number 133214-12-7, is a coordination compound formed between copper ions and flurbiprofen, a non-steroidal anti-inflammatory drug (NSAID). This complex exhibits unique characteristics due to the interaction between the metal ion and the organic ligand. Typically, such complexes can enhance the solubility and bioavailability of the drug, potentially leading to improved therapeutic effects. The presence of copper may also impart additional biological activities, such as antioxidant properties. The complex is generally characterized by its stability, which can be influenced by factors such as pH and the presence of other ions in solution. In terms of pharmacological applications, copper flurbiprofen complex may be explored for its efficacy in pain management and inflammation reduction, similar to flurbiprofen itself, but with the added benefits that metal coordination can provide. Further studies are often necessary to fully understand its pharmacokinetics, mechanisms of action, and potential side effects compared to the free drug.

CAS 133214-12-7

copper flurbiprofen complex

[1,1'-Biphenyl]-4-acetic acid, 2-fluoro-α-methyl-, copper(2+) salt (2:1)

Ref: IN-DA0014FB